After four decades of research, scientists have finally developed an effective vaccine in the fight against Ebola.  “Vaccine efficacy was 100 per cent,” the scientists behind the rVSV-ZEBOV vaccine wrote in their paper. While not yet approved by any regulatory authority for widespread use, in the trial of the vaccine in Guinea, West Africa, none of the 5,837 residents who received it contracted Ebola 10 or more days later. People who fell ill within the first nine days were discounted as it was assumed – given the incubation period of the disease – they had been infected before the vaccination was given.

Ebola is a devastating disease that during the 2013 to 2016 Ebola outbreaks in Africa took the lives of 11,300 people.

Read more at: Ebola vaccine gives 100% protection, trial shows